HEALTHJul 21 · 12:00 UTCSTAT NEWSBrittany Trang

STAT+: Nabla’s new CEO on plan to gain market share in a competitive AI scribe environment

Nabla, a Paris-based ambient scribe company, announced Brian Manning as its new CEO and reiterated its commitment to AI technology to compete in the clinical documentation market. The company plans to accelerate its U.S. market strategy by 2027, with 100% of its revenue currently coming from the U.S.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

NablaorganizationBrian ManningpersonDelphine GrollpersonPatientPingorganizationBamboo HealthorganizationAI scribe environmenttopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

TECHNOLOGYJul 20 · 10:59 UTC
STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
TECHNOLOGYJul 15 · 12:12 UTC
ASML raises forecasts as AI boom boosts sales
BUSINESSMay 6 · 18:33 UTC
FanDuel Names New Top Executive Amid Prediction Markets Push
HEALTHJul 16 · 12:00 UTC
STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
BUSINESSJun 28 · 05:00 UTC
Indian payments chief thinks AI will be heavily involved in next era of digital payment growth